R

Rapport Therapeutics

18 employees

Rapport Therapeutics is a clinical-stage biotechnology company that discovers and develops precision medicines for neurological disorders.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Medical
Life Science

Date founded

2022

Funding rounds raised

Total raised

$150M

from 9 investors over 9 rounds

R

Rapport Therapeutics raised $150M on August 23, 2023

Investors: Logos Global Management, LP, Surveyor Capital, Goldman Sachs Asset Management, Sofinnova Ventures, Russia technology fund, T. Rowe Price, Third Rock Ventures and Perceptive Advisors

R

Rapport Therapeutics raised $100M on March 7, 2023

Investors: ARCH Venture Partners and Third Rock Ventures

FAQ